PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
17.15
Positive P/E while Healthcare median is negative at -1.87. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
19.51
P/S exceeding 1.5x Healthcare median of 8.92. Jim Chanos would check for potential multiple compression risks.
0.64
P/B less than half the Healthcare median of 2.06. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-58.09
Negative FCF while Healthcare median P/FCF is -8.10. Seth Klarman would investigate cash flow improvement potential.
-63.86
Negative operating cash flow while Healthcare median P/OCF is -7.08. Seth Klarman would investigate operational improvement potential.
0.64
Fair value ratio less than half the Healthcare median of 2.06. Joel Greenblatt would investigate if this discount is justified.
1.46%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-1.72%
Negative FCF while Healthcare median yield is -1.35%. Seth Klarman would investigate cash flow improvement potential.